Literature DB >> 25560845

Liver: Sussing out statins in cirrhosis--KLF2 is the key.

Katrina Ray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25560845     DOI： 10.1038/nrgastro.2014.233

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins.

Authors:  Giusi Marrone; Raquel Maeso-Díaz; Guillermo García-Cardena; Juan G Abraldes; Juan Carlos García-Pagán; Jaime Bosch; Jordi Gracia-Sancho
Journal:  Gut       Date:  2014-12-10       Impact factor: 23.059
  1 in total
  3 in total

Review 1.  Sinusoidal communication in liver fibrosis and regeneration.

Authors:  Giusi Marrone; Vijay H Shah; Jordi Gracia-Sancho
Journal:  J Hepatol       Date:  2016-05-02       Impact factor: 25.083

Review 2.  Pleiotropic effects of statins in the diseases of the liver.

Authors:  Martin Janicko; Sylvia Drazilova; Daniel Pella; Jan Fedacko; Peter Jarcuska
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

3.  Role of Metabolism in Hepatic Stellate Cell Activation and Fibrogenesis.

Authors:  Wei Hou; Wing-Kin Syn
Journal:  Front Cell Dev Biol       Date:  2018-11-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.